176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth under 50% of AMD's 26.40%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
49.12%
Gross profit growth above 1.5x AMD's 30.66%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
241.17%
EBIT growth 1.25-1.5x AMD's 198.82%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
241.17%
Operating income growth similar to AMD's 251.56%. Walter Schloss would assume both share comparable operational structures.
204.73%
Net income growth at 75-90% of AMD's 238.30%. Bill Ackman would press for improvements to catch or surpass competitor performance.
196.15%
EPS growth above 1.5x AMD's 100.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
196.15%
Diluted EPS growth above 1.5x AMD's 100.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
9.26%
Share count expansion well above AMD's 1.15%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
9.26%
Diluted share reduction more than 1.5x AMD's 20.33%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
36.23%
OCF growth under 50% of AMD's 38859100.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
31.32%
FCF growth under 50% of AMD's 282.17%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
227.44%
10Y revenue/share CAGR above 1.5x AMD's 59.77%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
227.44%
5Y revenue/share CAGR above 1.5x AMD's 25.38%. David Dodd would look for consistent product or market expansions fueling outperformance.
227.44%
Positive 3Y CAGR while AMD is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
2003.06%
10Y OCF/share CAGR above 1.5x AMD's 15.05%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2003.06%
5Y OCF/share CAGR above 1.5x AMD's 185.30%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
2003.06%
3Y OCF/share CAGR above 1.5x AMD's 38.80%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
212.78%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
212.78%
5Y net income/share CAGR above 1.5x AMD's 58.74%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
212.78%
Positive short-term CAGR while AMD is negative. John Neff would see a clear advantage in near-term profit trajectory.
571.10%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
571.10%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
571.10%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.10%
AR growth is negative/stable vs. AMD's 12.15%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-29.26%
Inventory is declining while AMD stands at 0.76%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.78%
Negative asset growth while AMD invests at 6.45%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.92%
We have a declining book value while AMD shows 4.22%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.44%
We’re deleveraging while AMD stands at 0.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.70%
Our R&D shrinks while AMD invests at 5.84%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
145.70%
SG&A growth well above AMD's 7.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.